Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of Kendine 91, a novel histone deacetylase inhibitor, in mice plasma and tissues: application to a pharmacokinetic study

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jul 1;870(1):109-16. doi: 10.1016/j.jchromb.2008.06.013. Epub 2008 Jun 13.

Abstract

A liquid chromatography-tandem mass spectrometric method (LC-MS/MS) has been developed and validated to determine the concentration of Kendine 91 in mice plasma and tissues. Simvastatin was employed as the internal standard. Separation was performed on a C8 column, with a mobile phase consisting of methanol and aqueous 10 mM formic acid (73:27 v/v). Both analyte and internal standard were determined using electrospray ionization and the MS data acquisition was via multiple-reaction monitoring (MRM) in positive scanning mode. Quantification was performed using the transitions m/z 444-->169 and 441-->325 for Kendine 91 and simvastatin, respectively. The method was validated with respect to linearity, accuracy, precision, recovery and stability. This assay has been successfully applied to a pharmacokinetic study after intravenous injection of Kendine 91 in mice in a dose of 10mg/kg.

Publication types

  • Evaluation Study
  • Validation Study

MeSH terms

  • Animals
  • Calibration
  • Chromatography, Liquid / methods*
  • Enzyme Inhibitors / analysis*
  • Enzyme Inhibitors / blood
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / pharmacokinetics*
  • Histone Deacetylase Inhibitors*
  • Mice
  • Sensitivity and Specificity
  • Tandem Mass Spectrometry / methods*

Substances

  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors